GH Therapy in Non–Growth Hormone-Deficient Children
Before 1985, growth hormone (GH) was extracted from human pituitaries, and its therapeutic use was limited to children with severe GH deficiency (GHD). The availability of an unlimited amount of recombinant GH (rhGH) allowed for investigating the efficacy of its therapeutic use in a number of condit...
Saved in:
Main Authors: | Chiara Guzzetti, Anastasia Ibba, Valeria Incandela, Sandro Loche |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/12/1/3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validation of the Food Safe Zone questionnaire for families of individuals with Prader-Willi syndrome
by: Elisabeth M. Dykens, et al.
Published: (2025-02-01) -
Functional analysis of a novel homozygous missense IVD gene variant: a case report with dual genetic diagnoses
by: Yuying Zhu, et al.
Published: (2025-02-01) -
Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
by: Andrijana Koceva, et al.
Published: (2025-01-01) -
Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry
by: Shani A D Mathara Diddhenipothage, et al.
Published: (2025-01-01) -
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
by: Elisa Dinoi, et al.
Published: (2025-02-01)